Personalized Medicine Coalition Elects New Board Member

WASHINGTON, Dec. 11, 2012 /PRNewswire-USNewswire/ -- The Personalized Medicine Coalition (PMC) today announced that Julie K. Goonewardene was elected to the Coalition's board of directors for a three-year term beginning November 27, 2012.

(Photo: http://photos.prnewswire.com/prnh/20121211/DC27601)

"Our success in promoting personalized medicine is largely driven by our dedicated and engaged membership as well as an active board. Based on her dedication to moving science from the bench to the bedside, Julie can assist us in advocating for pro-innovation policies that will help patients and improve health care," said William S. Dalton, Ph.D., M.D., CEO M2Gen, director Personalized Medicine Institute at Moffitt Cancer Center, and vice chairman of the PMC.

Ms. Goonewardene currently serves as the public member of the American Medical Association (AMA) Board of Trustees, and her nomination to serve on the PMC board was supported by James L. Madara, M.D., Executive Vice President and CEO of the AMA. The AMA is the largest association of physicians and medical students in the United States. Its mission is to promote the art and science of medicine and the betterment of the public health.

"We are pleased that Julie is joining the PMC board and believe her extensive background and expertise in business and health care issues, particularly in the realm of bringing cutting-edge medical research to the bedsides of patients, will serve the PMC board well," said Dr. Madara.

In addition to serving in her current role as an AMA board member, Ms. Goonewardene is the Associate Vice Chancellor for Innovation and Entrepreneurship at the University of Kansas (KU), president of the KU Center for Technology Commercialization and a professor of practice in the KU School of Business. Prior to KU, she held various roles at Purdue University. She is an experienced entrepreneur, an author, and frequent speaker on innovation.  She earned a B.S with Honors in Management and a Masters in Health Communication from Purdue University.

"I am honored to join the PMC board and work with its exceptional team," Goonewardene said. "PMC has been a leader across the personalized medicine landscape for nearly a decade. I look forward to sharing my experiences and contributing to the development and adoption of personalized medicine."

About the Personalized Medicine Coalition: 
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.PersonalizedMedicineCoalition.org.

Contact:
Tiffany Harrington, Director, Public Affairs
[email protected]
(202) 589-1755

SOURCE Personalized Medicine Coalition